ABT-702 dihydrochloride is primarily used in research settings as a potent and selective adenosine kinase inhibitor. It is widely applied in studies focused on understanding the role of adenosine in various physiological and pathological processes. By inhibiting adenosine kinase, it increases extracellular adenosine levels, which can help modulate pain, inflammation, and neuroprotection. Researchers utilize it to explore its potential therapeutic effects in conditions such as chronic pain, epilepsy, and neurodegenerative diseases. Additionally, it serves as a valuable tool in pharmacological studies to investigate adenosine signaling pathways and their implications in cellular and molecular mechanisms.